跳至主要内容
临床试验/JPRN-UMIN000009158
JPRN-UMIN000009158已完成未知

AZELNIDIPINE COMBINED WITH ANGIOTENSIN RECEPTOR BLOCKER CAN RESTORE SYMPATHETIC ACTIVITY - Azelnidipine/ARB & Sympathetic activity

Division of Nephrology, Nafoya City University Hospital0 个研究点目标入组 20 人开始时间: 2012年10月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

Means of all normal-to-normal intervals over 24 h (p<0.0001) and DC (p=0.002) increased, and Lambda (p=0.001) decreased regardless of gender, age, renal function or blood pressure, while no significant changes were observed in the other HRVs. Reduction of Lambda is useful to assess the effect of sympathoinhibitory treatment. J Renin Angiotensin Aldosterone Syst. 2016 Apr 18;17(2):1470320316643905

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) polycystic kidney disease 2) arrhythmia 3) known history of angina pectoris, myocardial infarction, heart failure, stroke, or TIA

研究者

发起方
Division of Nephrology, Nafoya City University Hospital

相似试验